VKTX - Viking Therapeutics Inc
IEX Last Trade
64.14
1.490 2.323%
Share volume: 2,760,490
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$62.65
1.49
2.38%
Fundamental analysis
21%
Profitability
25%
Dept financing
2%
Liquidity
50%
Performance
15%
Performance
5 Days
-0.79%
1 Month
13.45%
3 Months
3.79%
6 Months
-32.15%
1 Year
368.88%
2 Year
1,910.03%
Key data
Stock price
$64.14
DAY RANGE
N/A - N/A
52 WEEK RANGE
$8.28 - $99.41
52 WEEK CHANGE
$3.42
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/23/2024
Company detail
CEO: Brian Lian
Region: US
Website: http://www.vikingtherapeutics.com
Employees: 18
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: http://www.vikingtherapeutics.com
Employees: 18
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
novel therapeutics for metabolic and endocrine disorders.
Recent news